Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Protection After Preeclampsia With Enalapril

NCT07222852 is registered in ClinicalTrials.gov with Women and Infants Hospital of Rhode Island as lead sponsor.

NCT NCT07222852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Protection After Preeclampsia With Enalapril
Lead sponsor
Women and Infants Hospital of Rhode Island
Phase
Phase 3
Overall status
Recruiting
Start date
January 1, 2026
Completion date
October 15, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational hypertension, gestational hypertension after childbirth, hypertension, hypertensive disorder of pregnancy, preeclampsia